|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hayat MJ, Howlader N, Reichman ME and
Edwards BK: Cancer statistics, trends, and multiple primary cancer
analyses from the Surveillance, Epidemiology, and End Results
(SEER) Program. Oncologist. 12:20–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Stegmaier C and Ziegler H:
Long-term survival of cancer patients in Germany achieved by the
beginning of the third millenium. Ann Oncol. 16:981–986. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kishi Y, Hasegawa K, Sugawara Y and Kokudo
N: Hepatocellular carcinoma: current management and future
development-improved outcomes with surgical resection. Int J
Hepatol. 2011:7281032011.PubMed/NCBI
|
|
5
|
Breuhahn K, Longerich T and Schirmacher P:
Dysregulation of growth factor signaling in human hepatocellular
carcinoma. Oncogene. 25:3787–3800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clendenen TV, Arslan AA, Lokshin AE, et
al: Temporal reliability of cytokines and growth factors in EDTA
plasma. BMC Res Notes. 3:3022010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao B, Zhang C, Forsten-Williams K, Zhang
J and Fannon M: Endothelial cell capture of heparin-binding growth
factors under flow. PLoS Comput Biol. 6:e10009712010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barbara L, Benzi G, Gaiani S, et al:
Natural history of small untreated hepatocellular carcinoma in
cirrhosis: a multivariate analysis of prognostic factors of tumor
growth rate and patient survival. Hepatology. 16:132–137. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chitnis MM, Yuen JS, Protheroe AS, Pollak
M and Macaulay VM: The type 1 insulin-like growth factor receptor
pathway. Clin Cancer Res. 14:6364–6370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Whittaker S, Marais R and Zhu AX: The role
of signaling pathways in the development and treatment of
hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurmasheva RT and Houghton PJ: IGF-I
mediated survival pathways in normal and malignant cells. Biochim
Biophys Acta. 1766:1–22. 2006.PubMed/NCBI
|
|
12
|
Shimizu M, Shirakami Y, Sakai H, et al:
EGCG inhibits activation of the insulin-like growth factor
(IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Cancer Lett. 262:10–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pi-Chieh Wang K, Lee LM, Lin TJ, et al:
Gene transfer of IGF1 attenuates hepatocellular apoptosis after
bile duct ligation. J Surg Res. 167:237–244. 2011. View Article : Google Scholar
|
|
14
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
15
|
Ting AH, Jair KW, Suzuki H, Yen RW, Baylin
SB and Schuebel KE: CpG island hypermethylation is maintained in
human colorectal cancer cells after RNAi-mediated depletion of
DNMT1. Nat Genet. 36:582–584. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patra SK, Patra A, Zhao H and Dahiya R:
DNA methyltransferase and demethylase in human prostate cancer. Mol
Carcinog. 33:163–171. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saito Y, Kanai Y, Nakagawa T, et al:
Increased protein expression of DNA methyltransferase (DNMT) 1 is
significantly correlated with the malignant potential and poor
prognosis of human hepatocellular carcinomas. Int J Cancer.
105:527–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Girault I, Tozlu S, Lidereau R and Bieche
I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in
sporadic breast carcinomas. Clin Cancer Res. 9:4415–4422.
2003.PubMed/NCBI
|
|
19
|
Etoh T, Kanai Y, Ushijima S, et al:
Increased DNA methyltransferase 1 (DNMT1) protein expression
correlates significantly with poorer tumor differentiation and
frequent DNA hypermethylation of multiple CpG islands in gastric
cancers. Am J Pathol. 164:689–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT
and Wang YC: Alteration of DNA methyltransferases contributes to
5′CpG methylation and poor prognosis in lung cancer. Lung Cancer.
55:205–213. 2007. View Article : Google Scholar
|
|
21
|
Lambert MP, Paliwal A, Vaissiere T, et al:
Aberrant DNA methylation distinguishes hepatocellular carcinoma
associated with HBV and HCV infection and alcohol intake. J
Hepatol. 54:705–715. 2011. View Article : Google Scholar
|
|
22
|
Lin RK, Hsieh YS, Lin P, et al: The
tobacco-specific carcinogen NNK induces DNA methyltransferase 1
accumulation and tumor suppressor gene hypermethylation in mice and
lung cancer patients. J Clin Invest. 120:521–532. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong C, Yuan T, Wu Y, et al: Loss of FBP1
by Snail-mediated repression provides metabolic advantages in
basal-like breast cancer. Cancer Cell. 23:316–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tiwari N, Tiwari VK, Waldmeier L, et al:
Sox4 is a master regulator of epithelial-mesenchymal transition by
controlling Ezh2 expression and epigenetic reprogramming. Cancer
Cell. 23:768–783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Au SL, Wong CC, Lee JM, Wong CM and Ng IO:
EZH2-mediated H3K27me3 is involved in epigenetic repression of
deleted in liver cancer 1 in human cancers. PLoS One. 8:e682262013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taketo MM: Shutting down Wnt
signal-activated cancer. Nat Genet. 36:320–322. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun L, Zhao H, Xu Z, et al:
Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes
DNA methyltransferase I protein and maintains DNA methylation. Cell
Signal. 19:2255–2263. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma X, Wang YW, Zhang MQ and Gazdar AF: DNA
methylation data analysis and its application to cancer research.
Epigenomics. 5:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurita S, Higuchi H, Saito Y, et al: DNMT1
and DNMT3b silencing sensitizes human hepatoma cells to
TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and
caspase-8. Cancer Sci. 101:1431–1439. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Jiang W, Aucejo F, et al:
Insulin-like growth factor I receptor beta expression in
hepatocellular carcinoma. Hum Pathol. 42:882–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agoston AT, Argani P, Yegnasubramanian S,
et al: Increased protein stability causes DNA methyltransferase 1
dysregulation in breast cancer. J Biol Chem. 280:18302–18310. 2005.
View Article : Google Scholar : PubMed/NCBI
|
